AIM IP specialist Tekcapital to sell or float all four portfolio companies 'within 2 years'. Watch the full video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7,717.00
Bid: 7,724.00
Ask: 7,727.00
Change: -18.00 (-0.23%)
Spread: 3.00 (0.04%)
Open: 7,690.00
High: 7,743.00
Low: 7,668.00
Yest. Close: 7,735.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

UPDATE 1-Switzerland 'unfortunately' still awaiting AstraZeneca COVID-19 vaccine data - official

Tue, 20th Apr 2021 14:23

(Adds details, background)

By John Miller

ZURICH, April 20 (Reuters) - Switzerland's drug regulator is
still awaiting data needed to consider AstraZeneca's
COVID-19 vaccine candidate for approval, a Swissmedic official
said on Tuesday, adding the information "unfortunately" had yet
to be submitted.

AstraZeneca was the first vaccine maker to seek approval
back in early October 2020, but has since been surpassed by
three vaccines that have won Swissmedic's blessing from Pfizer
, Moderna and Johnson & Johnson. Another
candidate, from Germany's CureVac, this week submitted
a rolling application, in hopes of a speedy OK.

Claus Bolte, Swissmedic's head of approvals, said
AstraZeneca's approval process had dragged on as part of a
"curious" situation, marked by the British-Swedish company's
release of initial, optimistic efficacy data in March that drew
a U.S. officials' rebuke, before days later issuing slightly
worse numbers.

"We're waiting, just like the U.S. Food and Drug
Administration, for the results of clinical trials in Latin
America and North America," Bolte said during a virtual press
conference from Bern.

"It was announced four weeks ago, but it has unfortunately
not yet been submitted," he said. "We want to decide on an
approval. Right now, however, it's not possible."

Also at the press conference, Swiss vaccines czar Nora
Kronig said that Moderna's COVID-19 vaccine deliveries
had experienced some hiccups and delays, but the Swiss
government still anticipated the U.S. company would fulfill its
commitments to Switzerland for the second quarter.

Moderna told Reuters last week that its second-quarter
deliveries to Britain and Canada would be delayed, but that
Swiss and European Union shipments would hit target ranges.

Switzerland expects to get eight million doses combined from
Moderna and Pfizer and its German partner BionTech in
April, May and June.
(Reporting by John Miller, editing by John Revill and Silke
Koltrowitz)

More News

TOP NEWS: PM Johnson confirms England lockdown easing on May 17

TOP NEWS: PM Johnson confirms England lockdown easing on May 17

Today 18:55

Amgen notes AstraZeneca makes US biologics application for asthma drug

Amgen notes AstraZeneca makes US biologics application for asthma drug

Today 17:24

UPDATE 1-AstraZeneca reaches vaccine shipping milestone as EU sues again

(adds legal case, duration of contract)By Francesco GuarascioBRUSSELS, May 10 (Reuters) - AstraZeneca Plc has delivered 50 million doses of its COVID-19 vaccine to European Union countries, according to EU supply data, a milestone the company had ...

Today 17:12

AstraZeneca finally reaches vaccine shipping milestone to EU that was due in January

By Francesco GuarascioBRUSSELS, May 10 (Reuters) - AstraZeneca Plc has delivered 50 million doses of its COVID-19 vaccine to European Union countries, according to EU's latest supply data, a milestone it was originally due to hit in January.Repeat...

Today 16:37

EU to launch new legal action against AstraZeneca over vaccine deliveries

BRUSSELS, May 10 (Reuters) - The European Commission will start on Tuesday a second legal case against AstraZeneca over its delayed deliveries of COVID-19 vaccines, a spokesman for the EU executive said on Monday.The move is mostly procedural afte...

Today 16:11

UPDATE 1-One AZ COVID-19 vaccine dose gives 80% lower death risk - English data

(Adds details, quote)LONDON, May 10 (Reuters) - Data from the rollout of AstraZeneca's COVID-19 vaccine shows one dose of the shot results in 80% less risk of death from the disease, Public Health England said on Monday.It also said protection aga...

Today 16:07

AstraZeneca plan to beef up CEO Soriot's pay packet faces scrutiny at AGM

LONDON, May 10 (Reuters) - A number of investor advisory groups have called on AstraZeneca shareholders to oppose plans to increase Chief Executive Pascal Soriot's pay package when the COVID-19 vaccine maker holds its annual meeting on Tuesday.As...

Today 13:51

Europe dares to reopen as 200 millionth vaccine dose delivered

By Michael Gore and Estelle ShirbonMADRID/LONDON, May 10 (Reuters) - As its vaccination drive reaches a third of adults and COVID-19 infections ease, Europe is starting to reopen cities and beaches, raising hopes that this summer's holiday season ...

Today 13:41

Europe dares to reopen as 200 millionth vaccine dose delivered

By Michael Gore and Estelle ShirbonMADRID/LONDON, May 10 (Reuters) - As its vaccination drive reaches a third of adults and COVID-19 infections ease, Europe is starting to reopen cities and beaches, raising hopes that this summer's holiday season ...

Today 13:41

Monday broker round-up

(Sharecast News) - St Modwen: Liberum downgrades to hold with a target price of 542p.

Today 13:05

Italy's Lazio region urges people to take AstraZeneca, J&J shots

ROME, May 10 (Reuters) - Italy's Lazio region, centred on the capital Rome, is urging people to book AstraZeneca and Johnson & Johnson COVID-19 shots, which have fallen out of favour with some residents over worries about possible side effects.Li...

Today 12:52

Norway's committee recommends dropping AstraZeneca, J&J jabs

Norway's committee recommends dropping AstraZeneca, J&J jabs

Today 12:08

Poland to shorten gap between COVID vaccine doses

WARSAW, May 10 (Reuters) - Poland will shorten the gap between doses for Pfizer, Moderna and AstraZeneca COVID-19 jabs, the minister responsible for Poland's vaccination programme said on Monday.The gap between doses for the Moderna and Pfizer vac...

Today 11:13

UPDATE 1-GAVI in talks with China's Sinopharm, other vaccine makers for COVAX doses

(Adds details, background)GENEVA, May 10 (Reuters) - The GAVI Vaccine Alliance is in talks with COVID-19 vaccine manufacturers including China's state-owned Sinopharm to expand the COVAX pipeline and secure doses for distribution, a GAVI spokeswom...

Today 10:13

Germany says reports of new side affects do not impact AstraZeneca vaccine recommendation

BERLIN, May 10 (Reuters) - Germany has no findings that would change its recommendation on the use of AstraZeneca's COVID-19 vaccine following reports of a rare nerve-degenerating disorder in people who received the shot, health minister Jens Spa...

Today 09:21

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.